| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-LHX3 (C-Term) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
LHX3 |
| Gene ID: |
8022 |
| Uniprot ID: |
LHX3_HUMAN |
| Immunogen Region: |
C-Term |
| Immunogen: |
A synthetic peptide corresponding to a sequence within amino acids 300 to the C-terminus of human LHX3 (NP_055379.1). |
| Immunogen Sequence: |
LEHGGLAGPEQYRELRPGSP YGVPPSPAAPQSLPGPQPLL SSLVYPDTSLGLVPSGAPGG PPPMRVLAGNGPSSDLSTGS SGGYPDFPASPASWLDEVDH AQF |
| Function | Transcription factor. Recognizes and binds to the consensus sequence motif 5'-AATTAATTA-3' in the regulatory elements of target genes, such as glycoprotein hormones alpha chain CGA and visual system homeobox CHX10, positively modulating transcription.transcription can be co-activated by LDB2. Synergistically enhances transcription from the prolactin promoter in cooperation with POU1F1/Pit-1. Required for the establishment of the specialized cells of the pituitary gland and the nervous system. Involved in the development of interneurons and motor neurons in cooperation with LDB1 and ISL1. |
| Protein Name | Lim/Homeobox Protein Lhx3Lim Homeobox Protein 3 |
| Database Links | Reactome: R-HSA-9010553 |
| Cellular Localisation | Nucleus |
| Alternative Antibody Names | Anti-Lim/Homeobox Protein Lhx3 antibodyAnti-Lim Homeobox Protein 3 antibodyAnti-LHX3 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
